PBC

·MeSH: Pruritus

13 drugs in development·12 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
maralixibat	Mirum Pharmaceuticals, Inc. (MIRM)

Phase 2(9)

Drug	Company
2mg cs0159	X4 Pharmaceuticals, Inc (XFOR)
CNP-104	IRONWOOD PHARMACEUTICALS INC (IRWD)
L-NMMA	Novartis AG (NVS)
L-NMMA	Cidara Therapeutics, Inc. (CDTX)
L-NMMA	Relay Therapeutics, Inc. (RLAY)
L-NMMA	ENANTA PHARMACEUTICALS INC (ENTA)
L-NMMA	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
L-NMMA	ADMA BIOLOGICS, INC. (ADMA)
reyobiq	PLUS THERAPEUTICS Inc. (PSTV)

Phase 1/Phase 2(2)

Drug	Company
golexanolone	COGNITION THERAPEUTICS INC (CGTX)
l-nmma	Galera Therapeutics, Inc. (GRTX)

Phase 4(1)

Drug	Company
LIVMARLI (maralixibat)	Mirum Pharmaceuticals, Inc. (MIRM)

BioSniper tracks 13 drugs in development for PBC across 12 companies.

There are 1 clinical trial targeting PBC tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.